ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-12381

Improper Privilege Management vulnerability in AlgoSec Firewall Analyzer on Linux, 64 bit allows Privilege Escalation, Parameter Injection.

Published Dec 9, 2025 · catalog updated Dec 9, 2025 · AlgoSec Firewall Analyzer

Last checked Nov 3, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-12381. EPSS is 0.16%. Act only if a listed version of AlgoSec Firewall Analyzer is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Medium6.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.16%
Remediation
Vendor / distro source
Affected products
vendor AlgoSec Firewall Analyzer A33.10 (up to build 220)

Improper Privilege Management vulnerability in AlgoSec Firewall Analyzer on Linux, 64 bit allows Privilege Escalation, Parameter Injection. A local user with access to the command line may escalate their privileges by abusing the parameters of a command that is approved in the sudoers file. This issue affects Firewall Analyzer: A33.0, A33.10.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor AlgoSec Firewall Analyzer A33.10 (up to build 220)A33.10 (up to build 220)

How to fix CVE-2025-12381

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-12381. EPSS is 0.16%. Act only if a listed version of AlgoSec Firewall Analyzer is installed.

Which versions are affected?

Compare what you have installed with AlgoSec Firewall Analyzer A33.10 (up to build 220) A33.10 (up to build 220). Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.16%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 9, 2025 · EUVD

    Detected

    Improper Privilege Management vulnerability in AlgoSec Firewall Analyzer on Linux, 64 bit allows Privilege Escalation, Parameter Injection. A local user with access to the command line may escalate their privileges by abusing the parameters of a command that is approved in the sudoers file. This issue affects Firewall Analyzer: A33.0, A33.10.

  2. Dec 9, 2025 · EUVD

    Updated

    Improper Privilege Management vulnerability in AlgoSec Firewall Analyzer on Linux, 64 bit allows Privilege Escalation, Parameter Injection. A local user with access to the command line may escalate their privileges by abusing the parameters of a command that is approved in the sudoers file. This issue affects Firewall Analyzer: A33.0, A33.10.

Sources

  • CVE.orgVulnerability recordCVE-2025-12381

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-12381

    30-day exploitation probability 0.16%

    first.org
  • EUVDVulnerability recordEUVD-2025-202049

    Improper Privilege Management vulnerability in AlgoSec Firewall Analyzer on Linux, 64 bit allows Privilege Escalation, Parameter Injection. A local user with access to the command line may escalate their privileges by abusing the parameters of a command that is approved in the su

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Nov 3, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSNov 3, 2026
  • CVE.orgOct 28, 2026
  • EUVDOct 27, 2026